Nemaura Medical Inc. (NMRD) |
| 0.0002 0 (100%) 05-29 16:00 |
| Open: | 0.0002 |
| High: | 0.0002 |
| Low: | 0.0002 |
| Volume: | 500 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | Other OTC |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 9.66 |
| Resistance 1: | 8.27 |
| Pivot price: | 8.04 |
| Support 1: | 7.92 |
| Support 2: | 7.71 |
| 52w High: | 0.0005 |
| 52w Low: | 1.0E-5 |
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
Financials
| EPS | 0.750 |
| Book Value | 8.090 |
| PEG Ratio | 0.81 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 16.71 |
| Operating Margin (%) | 18.66 |
| Return on Assets (ttm) | 0.6 |
| Return on Equity (ttm) | 10.1 |
Company news
Thu, 17 Aug 2023
Nemaura Medical wins regulatory nod for CGM in the Middle East - Drug Delivery Business
Wed, 17 May 2023
Sufyan Ismail Net Worth (2026) - GuruFocus
Thu, 26 Jan 2023
Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet - Business Wire
Fri, 06 Jan 2023
Timothy Christopher Johnson Net Worth (2026) - GuruFocus
Thu, 13 Oct 2022
Thomas Peter Moore Net Worth (2026) - GuruFocus
Tue, 22 Jun 2021
Steering the digital non-invasive CGM revolution - Open Access Government
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
